Carbostesin-Adrenalin 2
Carbostesin-Adrenalin 2 is a medicine authorised by Swissmedic under authorisation number 33998. The authorisation holder is Aspen Pharma Schweiz GmbH. The medicinal product code is Synthetic medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 04 June 1968 and the authorisation is valid without a time limit. ATC code N01BB51 places the medicine in the group Anesthetics.
| Authorisation number | 33998 |
|---|---|
| Name | Carbostesin-Adrenalin 2 |
| Full name | Carbostesin-Adrenalin 2,5 mg/ml, Injektions-/Infusionslösung |
| Authorisation holder | Aspen Pharma Schweiz GmbH |
| Medicinal product code | Synthetic medicines |
| Dispensing category | B · Prescription only |
| ATC code | N01BB51 |
| First authorisation | 04 June 1968 |
| Authorisation validity | unlimited |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Carbostesin-Adrenalin 2,5 mg/ml, Injektions-/Infusionslösung | B | 04 June 1968 |
| 2 | Carbostesin-Adrenalin 5 mg/ml, Injektionslösung | B | 04 June 1968 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 23 | 5 x 20 mL | Durchstechflasche(n) | N01BB51 | 01.02.2. | B |
| 58 | 5 x 20 mL | Durchstechflasche(n) | N01BB51 | 01.02.2. | B |
Scroll the table sideways
Other medicines from this authorisation holder
Frequently asked questions
Is Carbostesin-Adrenalin 2 authorised in Switzerland?
Yes. Carbostesin-Adrenalin 2 is authorised by Swissmedic under authorisation number 33998, data as of 01 September 2026. The authorisation is valid without a time limit.
Which dispensing category does Carbostesin-Adrenalin 2 have?
Carbostesin-Adrenalin 2 is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.
Who is the authorisation holder of Carbostesin-Adrenalin 2?
The authorisation holder is Aspen Pharma Schweiz GmbH. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.